• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Veramark Technologies

Veramark Technologies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis

    CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis

  2. IDC Announces New Winners of HPC Innovation Excellence Awards

    IDC Announces New Winners of HPC Innovation Excellence Awards

  3. Our Outlook for Consumer Cyclical Stocks

    The U.S. economy is in decent shape, but we are being even more selective given recent outperformance.

  4. Our Outlook for Consumer Cyclical Stocks

    As macro headwinds mount, we would look for a larger valuation discount among consumer cyclical names.

  5. Our Outlook for the Market

    As the risk of increasing inflation looms, the risk/reward opportunity in stocks does not signal a screaming buy to us at this point.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.